Discover B2B leads for Hospitals & Clinics industry
Identify and research relevant prospects for B2B lead generation on Hospitals & Clinics sector. Find their verified contact details to reach out to them, nurture and convert them into paying clients. Streamline the process of filtering B2B prospects by searching for bisinesses based on their specifics like location, name or category.
Businesses
Found 7 in our database
Found 79 in our records
HQ: Temple City, California, United States
Fulgent Therapeutics
Fulgent Therapeutics, LLC is a pharmaceutical compShow more...any focusing on developing and commercializing innovative cancer therapeutics.
HQ: Temple City, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Nov 7, 2022
Founded Date: 2011
Company Type: For Profit
Stock Symbol: NASDAQ:FLGT
Operating Status: Active
17 Emails
1 Phones
Main email format: ssmith@fulgentgenetics.com (69.2%)
-
James Liu
Director of System Architecture,Enterprise Systems Architect
j**u@fulgentgenetics.com
-
Lawrence Weiss
l****s@fulgentgenetics.com
-
Ming Hsieh
m*******h@fulgentgenetics.com
-
Alex Witterschein
a**************n@fulgentgenetics.com
-
Erin Heaney
e*****y@fulgentgenetics.com
-
Eric Chen
e******n@fulgentgenetics.com
-
Rod Gervacio
CLS Lead
r*******o@fulgentgenetics.com
-
Spencer Young
Solutions/Software Analyst/Scientist/Engineer
s****g@fulgentgenetics.com
-
Benjamin Ramos
Talent Acquisition Specialist
b****s@fulgentgenetics.com
-
Doreen Ng
VP, Operations & Compliance | General Manager (Houston)
d******g@fulgentgenetics.com
-
Natalie Prescott
General Counsel & Chief Privacy Officer
n*******t@fulgentgenetics.com
-
Hanlin Gao
Lab Director and Chief Scientific Officer
h**o@fulgentgenetics.com
-
Paul Kim
Chief Financial Officer
p**m@fulgentgenetics.com
-
General Inquiries
info@fulgentgenetics.com
-
Customer Service
lacsupport@fulgentgenetics.com
-
Unclassified inbox
insurance@fulgentgenetics.com
-
General Inquiries
info@fulgent-therapeutics.com
HQ: New York, New York, United States
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focusShow more...ed on targeted cancer therapies for genetically-defined patient populations.
HQ: New York, New York, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Oct 17, 2022
Founded Date: 2013
Company Type: For Profit
Stock Symbol: NASDAQ:LOXO
Operating Status: Active
11 Emails
0 Phones
Main email format: ssmith@loxooncology.com (87.5%)
-
Lee S Scheible
Director, Early Phase Oncology, Loxo Oncology at Lilly
l*******e@loxooncology.com
-
Jinmi Heo
Director
j**o@loxooncology.com
-
Tamas Benkovics
Director
t********s@loxooncology.com
-
Alba Luengo
Principal Scientist
a*****o@loxooncology.com
-
Bojana Jovanovic
Senior Scientific Lead, Clinical Biomarker Development
b********c@loxooncology.com
-
Tracey Marrone
Talent Acquisition Manager
t******e@loxooncology.com
-
Nathan Wright
Research Fellow
n*****t@loxooncology.com
-
Ipsita Roy
Sr. Program/Project Manager
i**y@loxooncology.com
-
Nisha Nanda
Director, Clinical Science and Development
n***a@loxooncology.com
-
General Inquiries
info@loxooncology.com
-
Unclassified inbox
clinicaltrials@loxooncology.com
HQ: Dublin, Dublin, Ireland
Shire
Shire biotechnology company that focuses on servinShow more...g people with rare diseases.
HQ: Dublin, Dublin, Ireland
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics, Wellness
Acquired by: Takeda
Business Type: Public
Employees: 10001+
Rounds: Venture - Series Unknown
Last Investment Activity: May 14, 2024
Founded Date: 1986
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NASDAQ:SHPG
Operating Status: Closed
9 Emails
0 Phones
Main email format: ssmith@shire.com (100.0%)
-
Katelyn Mallozzi
Head of Global Planning and Design
k*******i@shire.com
-
Scott Donald
UK Head of Neuroscience
s*****d@shire.com
-
Nirvan Hulangamuwa
Finance Business Partner
n**********a@shire.com
-
Victor Otcheretko
v*********o@shire.com
-
General Inquiries
info@shirehousing.com
-
General Inquiries
info@shirefoods.com
-
Unclassified inbox
golf@theshirelondon.com
-
Unclassified inbox
shire@woodanilling.wa.gov.au
-
Unclassified inbox
abcdefghij@shire.com
HQ: Cambridge, Massachusetts, United States
Intellia Therapeutics
Intellia Therapeutics is a genome editing company Show more...that develops curative gene-editing treatments.
HQ: Cambridge, Massachusetts, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 22, 2024
Founded Date: 2014
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:NTLA
Operating Status: Active
8 Emails
0 Phones
Main email format: sarah.smith@intelliatx.com (100.0%)
-
Eliana Clark
Chief Technical Officer
e**********k@intelliatx.com
-
Samantha Soukamneuth
Associate Director
s******************h@intelliatx.com
-
Mary Margaret McKee
m********e@intelliatx.com
-
Unclassified inbox
medicalinformation@intelliatx.com
-
Unclassified inbox
privacy@intelliatx.com
-
Unclassified inbox
abcdefghij@intelliatx.com
-
Unclassified inbox
lina.li@intelliatx.com
-
General Inquiries
info@intelliatx.com
HQ: Culver City, California, United States
NantOmics
NantOmics develops cloud-based molecular profilingShow more... tools that help guide cancer patients.
HQ: Culver City, California, United States
Specialized In: Hospitals & Clinics, Biotechnology, Cloud Computing, Healthcare & Medical
Business Type: Private
Employees: 11-50
Rounds: Series A
Last Investment Activity: Feb 26, 2024
Founded Date: 2012
Company Type: For Profit
Operating Status: Active
3 Emails
0 Phones
Main email format: s.s@nantomics.com (100.0%)
-
Ian Blumenfeld
Data Science at Clover Health
i*b@nantomics.com
-
Juergen Urbanski
VP Digital at Airbus Defence and Space
j*u@nantomics.com
-
Patrick Soon-Shiong
Founder, Chairman, CEO, President and Managing Director
-
Shahrooz Rabizadeh
Chief Scientific Officer
-
Todd Hembrough
President of Proteomics
-
General Inquiries
info@nantomics.com
HQ: Copenhagen, Hovedstaden, Denmark
Orphazyme
Orphazyme develops innovative new therapies for thShow more...e treatment of a family of serious genetic disorders called lysosomal storage diseases.
HQ: Copenhagen, Hovedstaden, Denmark
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Hospitals & Clinics
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Equity
Last Investment Activity: Feb 21, 2024
Founded Date: 2009
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:ORPH
Operating Status: Active
5 Emails
0 Phones
Main email format: sarah@orphazyme.com (100.0%)
-
Shilpa Chatlani
Senior Director, Medical Affairs
s****a@orphazyme.com
-
Anders Hinsby
Chief Executive Officer
-
Thomas Kirkegaard Jensen
Chief Scientific Officer
-
Paul Merrigan
Chief Commercial Officer
-
Claus Sundgreen
Medical Director
-
Thomas Blaettler
Chief Medical Officer
-
Christophe Bourdon
Chief Executive Officer
-
Tim Kanter
Vice President Market Access, Trade and Pricing
-
Anders Fink Vadsholt
Chief Financial Officer
-
General Inquiries
usmedinfo@orphazyme.com
-
General Inquiries
contact@orphazyme.com
-
Unclassified inbox
last_initial@orphazyme.com
-
Unclassified inbox
tlg@orphazyme.com
HQ: San Francisco, California, United States
Alector
Alector is combining state-of-the-art antibody tecShow more...hnology and recent discoveries in neuroimmunology and human genetics to develop novel.
HQ: San Francisco, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 28, 2024
Founded Date: 2013
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:ALEC
Operating Status: Active
4 Emails
0 Phones
Main email format: sarah.smith@alector.com (100.0%)
-
Arnon Rosenthal
Founder, President & Chief Executive Officer
a*************l@alector.com
-
Robert Paul
Chief Medical Officer
-
Virginia DeJesus-Rueff
VP of Portfolio and Program Management
-
Marina Roell
Principal Scientist
-
Charles Wolfus
VP of Technology and Digital Health
-
Herve Rhinn
Head of Target Discovery and Genomics
-
Kristina Vlaovic
Vice President of Regulatory Affairs & Pharmacovigilance
-
Calvin Yu
VP Finance
-
General Inquiries
info@alector.com
-
Customer Service
support@alector.com
-
General Inquiries
help@alector.com
- «
- 1
- »
We’re in beta testing! Sign up for free to unlock all the information on this page — no credit card required.